Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CSPC Ningbo Dahongying Pharmaceutical is a prominent Chinese pharmaceutical manufacturer based in Ningbo, Zhejiang Province. Established as a key subsidiary of the CSPC Pharmaceutical Group following its acquisition in 2010, the company focuses on the production of high-quality generic medications. Its extensive product portfolio covers several critical therapeutic areas, including anti-infectives, cardiovascular diseases, and gastrointestinal disorders. The company operates advanced manufacturing facilities that adhere to national GMP standards, producing various dosage forms such as tablets, capsules, and injections. Dahongying plays a vital role in CSPC's supply chain, contributing to both domestic healthcare needs and international export markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ningbo Dahongying Pharmaceutical.